Anti-vaccine chiropractors rising force of misinformation

Anti-vaccine chiropractors rising force of misinformation submitted by /u/BlankVerse
[link] [comments]


source https://www.reddit.com/r/Health/comments/q4wf9k/antivaccine_chiropractors_rising_force_of/

Mayo Clinic offers program to help COVID-19 “long haulers”

Mayo Clinic offers program to help COVID-19 “long haulers” submitted by /u/shallah
[link] [comments]

Mayo Clinic offers program to help COVID-19 “long haulers”

Mayo Clinic offers program to help COVID-19 “long haulers” submitted by /u/shallah
[link] [comments]


source https://www.reddit.com/r/Health/comments/q4qhe8/mayo_clinic_offers_program_to_help_covid19_long/

20L vaccine doses given to pregnant women so far: Govt

20L vaccine doses given to pregnant women so far: Govt While exactly how many pregnant women have received Covid vaccine doses is not known, an estimated 50-60% of the total pregnant women at present are likely to have got at least one dose of the jabs either before they conceived or during pregnancy. https://ift.tt/eA8V8J

Government applies quantitative restriction on export of certain types of syringes

The quantitative restriction on the export of certain types of specified syringes will be applied for a limited duration of 3 months, the Union Health Ministry said.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3FxIz2I
via gqrds

Government applies quantitative restriction on export of certain types of syringes

Government applies quantitative restriction on export of certain types of syringes The quantitative restriction on the export of certain types of specified syringes will be applied for a limited duration of 3 months, the Union Health Ministry said. https://ift.tt/eA8V8J

Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir

Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravir Last week, Aurobindo Pharma and MSN Laboratories presented the interim clinical trial data in moderate patients before the the Subject subject expert committee (SEC) — the expert panel under the Drug Controller General of India (DCGI). https://ift.tt/eA8V8J